Esposito, Giovanna http://orcid.org/0000-0001-7894-4456
Somigliana, Edgardo
Franchi, Matteo
Dallagiovanna, Chiara
Pisaturo, Valerio
Corrao, Giovanni
Parazzini, Fabio
Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (2017728JPK)
Article History
Received: 1 April 2021
Accepted: 24 June 2021
First Online: 9 July 2021
Declarations
:
: This analysis is exempt from IRB authorization and informed consent (according to General Authorization for the Processing of Personal Data for Scientific Research Purposes issued by the Italian Privacy Authority on December 15, 2016; ExternalRef removedhome/docweb/-/docweb-display/docweb/5805552). Data and permission for the analysis were obtained by the Regional Health Authorities of Lombardy, Italy.
: Not applicable
: Dr. Edgardo Somigliana reports grants from Ferring, grants and personal fees from Merck-Serono, grants and personal fees from Theramex, personal fees from Gedeon-Richter, outside the submitted work. Prof. Giovanni Corrao received research support from the European Community (EC), the Italian Agency of Drugs (AIFA), and the Italian Ministry for University and Research (MIUR). He took part in a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, and BMS). He also received honoraria as a member of the advisory board to Roche. All the other authors declare that they have no conflicts of interest to disclose.